Figure 1

(A) Selected outcome measures to determine underlying liver disease, hyperammonemia and neurological deficits according to ISHEN guidelines. (B) Timeline detailing timing of outcome measure assessment after BDL in both C57Bl/6j and Swiss mice. BDL bile duct ligation, ISHEN International society for hepatic encephalopathy and nitrogen metabolism.